Showing results (1561-1570 of 2,014) with videos related to
Sort By:
Pageof 202
Frontiers in Immunology|August 4, 2025
Uncovering hidden immune defects in childhood granulomatous disorders: a case reportWalter Maria Sarli, Francesca Quaranta, Clementina Canessa, et al.RMD Open|May 4, 2026
Heat-not-burn tobacco induces protein post-translational modifications and apoptosis in bronchial cells: possible role in rheumatoid arthritisClaudia Ciancarella, Federica Maria Ucci, Valeria Manganelli, et al.Future Oncology (London, England)|May 10, 2018
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?Enrico Franceschi, Giuseppe Lamberti, Michela Visani, et al.Healthcare (Basel, Switzerland)|April 23, 2022
Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical SettingValentina Perrone, Melania Dovizio, Chiara Veronesi, et al.Journal of Medicinal Chemistry|July 9, 2008
Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rushMichela Rosini, Elena Simoni, Manuela Bartolini, et al.Journal of Extracellular Vesicles|September 7, 2013
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitroErika Bartolini, Elvira Ianni, Elisabetta Frigimelica, et al.Frontiers in Neurology|October 23, 2018
Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional StudyLuca Bartolini, Eleonora Piras, Kathryn Sullivan, et al.European Journal of Medicinal Chemistry|January 9, 2017
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's diseaseJakub Jeřábek, Elisa Uliassi, Laura Guidotti, et al.CNS Neuroscience & Therapeutics|June 18, 2014
Disease-modifying anti-Alzheimer's drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregationSimone Brogi, Stefania Butini, Samuele Maramai, et al.European Journal of Medicinal Chemistry|November 21, 2012
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agentsStefano Rizzo, Andrea Tarozzi, Manuela Bartolini, et al.Pageof 202